The Risk of Cardiometabolic Conditions Among Patients With Oral Candidiasis: A Global Large‐Scale Population‐Based Study
Journal of Oral Pathology & Medicine · 2026
DOI: 10.1111/jop.70105 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Oral Pathology & Medicine, 2026. Verfasst von Samer Kridin und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oral and Maxillofacial Surgery, Galilee College of Dental Sciences, Galilee Medical Center, Nahariya, Israel. Hauptthemen laut MEDLINE: Candidiasis, Oral, Cardiovascular Diseases, Metabolic Diseases. Die Arbeit nennt 25 Literaturangaben.
Abstract (Originalsprache)
Background
The cardiometabolic burden of oral candidiasis (OC) is yet to be thoroughly elucidated.
Objective
To assess the risk of long‐term cardiovascular and metabolic outcomes in patients with OC relative to those with two other common oral conditions: herpes simplex virus (HSV) infections and recurrent aphthous stomatitis (RAS).
Methods
A global retrospective cohort study comprised two analyses comparing patients with OC to those with HSV and RAS. The study groups were compared regarding the risk of 11 different cardiovascular and four metabolic outcomes. Propensity score matching was performed to optimize inter‐group comparability.
Results
Relative to those with HSV infections, patients with OC were found to experience a higher risk of stroke (HR, 1.78; 95% CI, 1.65–1.92), sudden cardiac death (HR, 2.46; 95% CI, 2.14–2.82), congestive heart failure (CHF; HR, 1.92; 95% CI, 1.80–2.06), hypertension (HR, 1.56; 95% CI, 1.50–1.62), hyperlipidemia (HR, 1.18; 95% CI, 1.13–1.24), type‐2 diabetes mellitus (DM; HR, 1.72; 95% CI, 1.63–1.81), and obesity (HR, 1.32; 95% CI, 1.27–1.38). Compared to RAS, OC demonstrated an elevated risk of myocardial infarction (HR, 1.47; 95% CI, 1.40–1.54), stroke (HR, 1.30; 95% CI, 1.25–1.36), pulmonary embolism (HR, 2.23; 95% CI, 2.11–2.35), peripheral vascular disease (HR, 1.35; 95% CI, 1.29–1.41), atrial fibrillation (HR, 1.61; 95% CI, 1.55–1.68), CHF (HR, 1.79; 95% CI, 1.73–1.86), hyperlipidemia (HR, 1.36; 95% CI, 1.33–1.40), DM (HR, 1.44; 95% CI, 1.40–1.48), and obesity (HR, 1.30; 95% CI,1.27–1.34).
Conclusion
OC is associated with an elevated risk of cardiometabolic outcomes. Physicians managing patients with OC should be aware of these associations.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Oral and Maxillofacial Surgery, Galilee College of Dental Sciences, Galilee Medical Center, Nahariya, Israel.
- The Azrieli Faculty of Medicine, Bar-Ilan University, Safed, Israel.
- School of Medicine, Royal College of Surgeons in Ireland, Manama, Bahrain.
- Unit of Dermatology and Skin Research Laboratory, Galilee Medical Center, Nahariya, Israel.
- Lűbeck Institute of Experimental Dermatology, University of Lübeck, Lübeck, Germany.
ORCID-Profile: Mariam Abdelghaffar, Khalaf Kridin
Zitieren
APA
Kridin, S., Karayanni Matanis, H., Redenski, I., Abdelghaffar, M., Srouji, S., & Kridin, K. (2026). The Risk of Cardiometabolic Conditions Among Patients With Oral Candidiasis: A Global Large‐Scale Population‐Based Study. Journal of Oral Pathology & Medicine. https://doi.org/10.1111/jop.70105
Vancouver
Kridin S, Karayanni Matanis H, Redenski I, Abdelghaffar M, Srouji S, Kridin K. The Risk of Cardiometabolic Conditions Among Patients With Oral Candidiasis: A Global Large‐Scale Population‐Based Study. Journal of Oral Pathology & Medicine. 2026. doi:10.1111/jop.70105
BibTeX
@article{Kridin2026,
author = {Kridin, Samer and Karayanni Matanis, Hala and Redenski, Idan and Abdelghaffar, Mariam and Srouji, Samer and Kridin, Khalaf},
title = {The Risk of Cardiometabolic Conditions Among Patients With Oral Candidiasis: A Global Large‐Scale Population‐Based Study},
journal = {Journal of Oral Pathology & Medicine},
year = {2026},
doi = {10.1111/jop.70105}
}
EUVIMED